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LETTERS
Rat-bite Fever,
Canada
To the Editor: Rat-bite fever was
once considered an infection exclu-
sive to children living in poverty;
however, dense urban housing and
changing pet-keeping practices may
be altering this profile (1,2). To date,
≈200 cases of rat-bite fever have been
reported in the United States (3), and
a recent study reported a 2-fold
increased incidence in California dur-
ing the 1990s (1). We report on 2
cases that occurred in Ontario,
Canada, in the early 2000s. 
The first case occurred in a previ-
ously healthy 29-year-old man who
was bitten on the finger by a pet rat.
The wound healed spontaneously.
After 24 hours, fever and emesis devel-
oped; 4 days later, diffuse maculopapu-
lar rash and migratory arthritis of the
knees, ankles, and finger joints ensued.
Physical examination showed a macu-
lopapular rash over the lower extremi-
ties, an effusion of the left knee, and a
warm, erythematous left ankle.
Laboratory investigations showed
hemoglobin level of 134 g/L, leuko-
cyte count of 16.0×109/L, and neu-
trophil count of 13.8×109/L. Aspira-
tion of the knee produced 70 cm3 of
cloudy fluid; synovial fluid analysis
showed 666×106/L leukocytes with a
predominance of neutrophils.
Ceftriaxone, 2 g once a day, was
given intravenously for 7 days.
Although symptoms improved within
24 hours, the effusion recurred within
48 hours of discontinuing the initial
course of ceftriaxone. The knee was
surgically drained, and ceftriaxone
was continued for 5 weeks. Systemic
symptoms and the effusion resolved.
The second case occurred in a pre-
viously healthy 9-year-old girl who
had mucosal contact with a pet rat.
She sought treatment after 7 days of
generalized maculopapular and pustu-
lar rash and 10 days of fever and
headache. She had an associated
asymmetric, migratory arthritis. 
Physical examination showed
superficial scratches from the rat;
temperature of 39.6°C; heart rate of
102 bpm; swelling, erythema, and
decreased range of motion in several
joints; and pustular lesions on the
soles of the feet.
The patient’s leukocyte count was
8.3×109/L. Synovial fluid from the
knee showed 45.5×106/L leukocytes
with 89% neutrophils; the culture
showed no growth. Gram stains of
blood and pustule swabs showed
large, pleomorphic, gram-negative
bacilli with long filaments and irregu-
lar swellings. Growth occurred on the
blood culture after 28 hours of aerobic
incubation at 35°C in 10% horse
serum. Characteristic puff-ball
colonies of Streptobacillus monili-
formis were seen in supplemented
thioglycolate broth. 
Identification of the organism was
confirmed by using the Sherlock
(MIDI Inc., Newark, DE, USA) sys-
tem. The major cellular fatty acid
components of the isolate matched an
S. moniliformis reference strain. The
patient received penicillin and gen-
tamicin intravenously for 6 days and
was discharged home with a 10-day
regimen of amoxicillin. One year
later, she remained asymptomatic.
Rat-bite fever commonly results
from infection with the zoonotic
pathogens  S. moniliformis and
Spirillum minus.  S. moniliformis is
more common in Western countries,
and  S. minus predominates in Asia
(3).  S. moniliformis colonizes the
nasopharynx of healthy rats (4) and is
transmitted by the bite or scratch of
rats, squirrels, mice, guinea pigs, and,
rarely, cats and other rodent preda-
tors. Occasionally, it is transmitted by
ingestion of contaminated milk or
water. (5,6). The site of inoculation
with  S. moniliformis usually heals
before systemic symptoms develop.
After the incubation period of 1 to 22
days, patients experience fever,
chills, myalgia, headache, and rash.
The rash consists of macules, vesi-
cles, and pustules on the extremities;
soles and palms are frequently
involved. Joint symptoms range from
polyarthralgia to migratory pol-
yarthritis with purulent effusions. A
nonsuppurative migratory polyarthri-
tis occurs in ≈50% of patients (5,7).
In rare cases, rash and arthritis may
be absent (8).
When  S. minus (a spirochete) is
introduced by rat bite, the bite wound
initially heals but then ulcerates, fol-
lowed by regional lymphadenopathy
and a distinctive rash of red and pur-
ple plaques. Arthritic symptoms are
rare (9).
Complications of rat-bite fever
include destructive joint disease, peri-
carditis, endocarditis, abscesses,
pneumonia, parotitis, pancreatitis,
and, rarely, meningitis and amnionitis.
Development of endocarditis results
in a mortality rate of up to 50% (5).
S. moniliformis can be isolated and
cultured from synovial fluid, blood,
and abscesses. By contrast, S. minus
has not been recovered on artificial
media but can be seen by using dark-
field microscopy with Giemsa or
Wright stains.
Laboratory personnel must be
notified when rat-bite fever is sus-
pected because S. moniliformis does
not grow in a routine sheep blood or
MacConkey agar; it requires rat or
horse serum, defibrinated blood, or
ascitic fluid to sustain growth. Growth
of S. moniliformis is inhibited by sodi-
um polyanetholesulfonate, a sub-
stance that is added to blood culture
bottles to inhibit the antimicrobial
action of blood (4,8). 
Optimal treatment for rat-bite
fever is penicillin G given intra-
venously for 7 to 10 days, followed by
penicillin V taken orally for 7 days.
Alternatively, tetracycline may be
used (5,7,9). 
Although rat-bite fever is uncom-
mon, it is increasingly seen as a result
of changing patterns of urban living
and pet-keeping practices. If unrec-
ognized, this infection can have
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debilitating sequelae and can be life
threatening.
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Cutaneous Injury
and Vibrio 
vulnificus Infection 
To the Editor: Vibrio vulnificus
infection is transmitted by eating con-
taminated seafood or by exposure to
seawater through an open wound (1).
Among immunocompromised per-
sons, especially those with chronic
liver disease, V. vulnificus can cause a
life-threatening illness characterized
by blistering skin lesions, necrotizing
fasciitis, and septic shock (2–5).
However, the epidemiology and risk
factors for severe forms of V. vulnifi-
cus infection among healthy persons
are less well documented (4–6).
We conducted a retrospective clin-
ical record review of V. vulnificus
infections in persons admitted to all
public hospitals from January 1, 2003,
through August 31, 2005, in Hong
Kong, which has a population of >6
million persons. We defined a case-
patient as a patient with culture of V.
vulnificus from any clinical specimen.
A record search of clinical case notes
was performed through a computer-
ized clinical management system
maintained by the Hospital Authority,
which manages all public hospitals in
Hong Kong. For each case-patient
identified, we reviewed demographic
data (age, sex, occupation, residence),
clinical and laboratory data (date of
onset, symptoms, laboratory investi-
gation findings, diagnosis, outcome),
and potential risk factors (past health
and possible source of exposure)
associated with the case. We com-
pared previously healthy patients with
patients who had predisposing med-
ical conditions in terms of demo-
graphic profile, clinical signs and
symptoms and outcome, and known
exposure factors. Mann-Whitney U
tests,  χ2 tests, or Fisher exact tests
were used to detect significant differ-
ences (α = 0.05).
We identified 29 cases over the 32-
month study period. Twenty-two
(76%) patients had disease onset from
May through August, the summer sea-
son in Hong Kong. Fifteen (52%)
cases were in men, and the median
age was 70 years (range 24–82 years).
Fifteen (52%) patients had underlying
illnesses that were known to predis-
pose them to V. vulnificus infection,
including chronic liver disease (30%),
chronic renal failure (15%), diabetes
mellitus (7%), and thalassemia major
(3%). Fourteen (48%) patients were
previously healthy. No significant dif-
ferences in age and sex were found.
Among the 14 previously healthy
patients, the consequences of V. vul-
nificus infection included necrotizing
fasciitis (70%), severe cellulitis (7%),
primary septicemia (14%), and gas-
troenteritis (7%). Two patients who
had necrotizing fasciitis and 1 patient
with primary septicemia died.
Compared with patients with predis-
posing medical conditions, patients
with a history of good health had a
higher (but not significant) proportion
of necrotizing fasciitis (70% vs 47%,
p = 0.12), a lower proportion of sep-
ticemia (14% vs. 27%, p = 0.26), and
an equal number of severe cases of
cellulitis (7% vs. 7%). Furthermore,
fewer patients with a history of good
health died than did patients with pre-
disposing illnesses (21% vs. 33%, p =
0.25). The median duration between
symptom onset and admission for all
patients was 1 day (range 0–3 days),
with no significant difference between
the 2 groups.
A history of cutaneous injury or a
skin prick from a seafood part (e.g.,
fish fin, shrimp spine, or crab leg) was
significantly more common among
previously healthy patients than
among patients with predisposing ill-
nesses (70% vs. 27%, p = 0.02). Ten
(83%) of the 12 previously healthy
patients with necrotizing fasciitis and
septicemia reported a history of cuta-
neous injury. The corresponding pro-
portion was significantly lower (31%)
among patients with predisposing
medical conditions (p = 0.01). Among
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